/
EVARF
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | |
|---|---|---|
| Revenue | $15.1M | $12.2M |
| Cost of revenue | $8.6M | $11.2M |
| Gross profit | $6.6M | $955.0K |
| Gross margin | 43.4% | 7.8% |
| R&D | $11.0M | $7.5M |
| Operating income | −$39.5M | −$29.3M |
| EBITDA | −$37.4M | −$28.1M |
| Net income | −$37.8M | −$31.0M |
| Net margin | -250.1% | -255.0% |
| EPS (diluted) | -2.13 | -1.54 |
Annual figures · source: Financial Modeling Prep
Peer comparison
LOMBARD MEDICAL INC
LOMBARD MEDICAL INC
Held by traders on TradeandTell
No one on the platform currently holds EVARF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in EVARF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded EVARF yet.
